文献速递血液淋巴病理细胞病理与分子病理

小体积活检在滤泡性淋巴瘤初诊与复发/转化中的诊断效能

Small volume biopsy diagnostic yield at initial diagnosis versus recurrence/transformation of follicular lymphoma: A retrospective Cyto-Heme Interinstitutional Collaborative study.
PubMed 文献 · Cancer Cytopathol · 2022-12-27

该多机构回顾性研究分析了676例以细针穿刺和针芯活检起始的滤泡性淋巴瘤检查。初诊时需多次活检比例更高、平均活检数更多(1.7 vs 1.1)、首次活检完整诊断率更低(39% vs 56%)。初诊时针芯活检±细针穿刺优于细针穿刺±针芯活检;复发/转化评估时不同活检类型所需活检数相似且极少需多次活检。

要点

  • 初诊滤泡性淋巴瘤小体积活检常需额外活检才能完整诊断。
  • 初诊时针芯活检±细针穿刺的完整诊断率高于细针穿刺±针芯活检(71% vs 18%)。
  • 评估复发/转化时小体积活检通常已足够,无需常规追加活检。

核心结论

  • 初诊滤泡性淋巴瘤的小体积活检常需追加活检以确立完整诊断。
  • 评估复发/转化时,无论小体积活检类型如何,通常不再追加活检,提示小体积活检可能足以支持临床决策。

研究设计与样本

  • 多机构回顾性分析,共评估676例以细针穿刺和/或针芯活检起始的检查。
  • 比较初诊与疑似复发/转化两组,并比较针芯活检±细针穿刺与细针穿刺±针芯活检。

主要发现

  • 初诊组较复发/转化组更可能需要多次活检(p < .01)。
  • 初诊组平均每次检查活检数更高(1.7 vs 1.1,绝对标准化差异=1.1)。
  • 初诊组首次活检完整诊断率更低(39% vs 56%)。
  • 初诊时针芯活检±细针穿刺较细针穿刺±针芯活检平均活检数更少(1.2 vs 1.9)、需多次活检比例更低(23% vs 83%)、完整诊断率更高(71% vs 18%)。
  • 复发/转化评估时,针芯活检与细针穿刺平均活检数相似(1.2 vs 1.2),需多次活检比例均低(6% vs 19%)。

关键数值与推荐

  • 初诊滤泡性淋巴瘤:针芯活检±细针穿刺完整诊断率71%,细针穿刺±针芯活检18%。
  • 初诊滤泡性淋巴瘤:针芯活检±细针穿刺需多次活检比例23%,细针穿刺±针芯活检83%。
  • 复发/转化评估:针芯活检需多次活检比例6%,细针穿刺19%。

临床怎么用

  • 初诊疑似滤泡性淋巴瘤时优先采用针芯活检(可联合细针穿刺)以提高首次活检完整诊断率。
  • 评估复发或转化时,小体积活检结果通常可支持临床决策,不必常规追加活检。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Few studies have evaluated diagnostic yield of small volume biopsies (SVB) for the diagnosis and management of follicular lymphoma (FL). METHODS: The authors performed a multi-institutional retrospective analysis of SVBs including fine-needle aspiration (FNA) and needle core biopsy (NCB) for initial FL diagnosis and suspected recurrence or transformation of FL. A total of 676 workups beginning with SVB were assessed for the mean number of biopsies per workup, the proportion of workups requiring multiple biopsies, and the proportion with a complete diagnosis including grade, on initial biopsy. RESULTS: Compared to workups performed for question transformation/recurrence, those done for initial FL diagnosis were significantly more likely to require multiple biopsies (p < .01), had a higher mean number of biopsies per workup (1.7 vs. 1.1, absolute standardized difference = 1.1), and a lower complete diagnosis rate at initial biopsy (39% vs. 56%). At initial FL diagnosis, NCB +/- FNA was associated with fewer biopsies per workup compared to FNA +/- CB (1.2 vs. 1.9), fewer workups requiring multiple biopsies (23% vs. 83%), and a higher complete diagnosis rate (71% vs. 18%). In contrast, during assessment for transformation/recurrence, NCB and FNA showed a similar mean number of biopsies per workup (1.2 vs. 1.2) and few workups required multiple biopsies (6% vs. 19%). CONCLUSIONS: SVB at initial FL diagnosis often required additional biopsies to establish a complete diagnosis. In contrast, when assessing for transformed/recurrent FL, additional biopsies were generally not obtained regardless of SVB type, suggesting that in these clinical settings SVB may be sufficient for clinical decision-making.

来源:Cancer Cytopathol,查看原文。版权归原作者所有。

引用

  1. Fitzpatrick MJ, Sundaram V, Ly A, et al. Small volume biopsy diagnostic yield at initial diagnosis versus recurrence/transformation of follicular lymphoma: A retrospective Cyto-Heme Interinstitutional Collaborative study. Cancer Cytopathol. 2022. PMID: 36573933. doi:10.1002/cncy.22676

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。